null

TPO-R/CD110/c-Mpl Rabbit Monoclonal Antibody (CAB19729)

(No reviews yet) Write a Review
SKU:
CAB19729
Product Type:
Antibody
Antibody Type:
Monoclonal Antibody
Reactivity:
Human Mouse Rat
Host Species:
Rabbit
Synonyms:
MPLV TPOR C-MPL CD110 THPOR THCYT2 TPO-R/CD110/c-Mpl
€131 - €457
Frequently bought together:

Description

system_update_altDatasheetsystem_update_altMSDS

TPO-R/CD110/c-Mpl Monoclonal Antibody (CAB19729)

The TPO-R/CD110/c-Mpl Monoclonal Antibody (CAB19729) is a high-quality antibody developed for reliable detection and analysis of target proteins. In 1990 an oncogene, v-mpl, was identified from the murine myeloproliferative leukemia virus that was capable of immortalizing bone marrow hematopoietic cells from different lineages. In 1992 the human homologue, named, c-mpl, was cloned. Sequence data revealed that c-mpl encoded a protein that was homologous with members of the hematopoietic receptor superfamily. Presence of anti-sense oligodeoxynucleotides of c-mpl inhibited megakaryocyte colony formation. The ligand for c-mpl, thrombopoietin, was cloned in 1994. Thrombopoietin was shown to be the major regulator of megakaryocytopoiesis and platelet formation. The protein encoded by the c-mpl gene, CD110, is a 635 amino acid transmembrane domain, with two extracellular cytokine receptor domains and two intracellular cytokine receptor box motifs . TPO-R deficient mice were severely thrombocytopenic, emphasizing the important role of CD110 and thrombopoietin in megakaryocyte and platelet formation. Upon binding of thrombopoietin CD110 is dimerized and the JAK family of non-receptor tyrosine kinases, as well as the STAT family, the MAPK family, the adaptor protein Shc and the receptors themselves become tyrosine phosphorylated.

This antibody is validated for use in WB, ELISA applications and has demonstrated reactivity against Human, Mouse, Rat samples.

0 Reviews

View AllClose